CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


<
Abbott Laboratories  (ABT)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 



 

Abbott Laboratories

ABT's Financial Statements and Analysis




Abbott Laboratories reported in I. Quarter net earnings per share of $0.24 an increase by 0 % year on year from $0.21 and decline of 0 % from $0.54 earned in IV. Quarter (Dec 31 2016).

Abbott Laboratories's Revenue rose by % in I. Quarter (Mar 31 2017) year on year, to $6,335 million and advanced by 18.79 % sequentially.


Abbott Laboratories is
More on ABT's Income Statement

I. Quarter
Earnings Per Share Revenues
$ 0.24 $  6,335 Mill
$+0.03     +14.29 % $+1,450M     +29.68 %
You need to upgrade your Flash Player


       
  • Established Pharmaceutical Products 24.64% Y/Y,
• Pediatric Nutritionals 3.95% Y/Y,
• Nutritionals 0.11% Y/Y
   
     
       
  • Adult Nutritionals -1.92% Y/Y,
• Endovascular -0.77% Y/Y,
• Vascular -7.95% Y/Y,
• Diagnostics -2.03% Y/Y,
• Other -10.06% Y/Y
   
     


ABT's Segments

ABT's NET INCOME

Abbott Laboratories's net income of $419 million in I. Quarter increased by 32.59 % from net earnings of $316 million achieved in I. Quarter a year ago.

Sequentially net earnings fell by -47.49 % from net income of $798.00 million realized in previous quarter.

More on ABT's Growth



Abbott Laboratories Income Growth by Division
• Established Pharmaceutical Products 10.63% Y/Y,
• Nutritionals 24.39% Y/Y • Vascular -14.64% Y/Y,
• Diagnostics -0.97% Y/Y Inventories Inventories grew by 43.4 % to $3,995 million from I. Quarter a year ago, sequentially inventories rose by 64.13 %. In I. Quarter company's net cash and cash equivalents decreased by $-9,914 million, capital expenditures fell by 11.93%, to $-272 millions compare to same quarter a year ago and rose by -14.73% from IV. Quarter (Dec 31 2016).

More on ABT's Cash flow Statement



Abbott Laboratories payed out dividend of $1.04 per share in last 52 weeks representing 107.22 % of net earning per share in trailing twelve-month period.

During the same period Abbott Laboratories earned $ 1.91 cash per share, on a free-cash flow basis 196.72 % of net earning per share.

Book value grew by 30.89 % sequentially to $18.18 per share, 428.28% of net income per share in trailing twelve-month period were contributed to shareholder value.


Company issued 243.73 million shares or 16.34 % in I. Quarter.
Interest Coverage Ratio was 4.58. Debt Coverage Ratio was 0.17.

More on ABT's Dividends
 Market Capitalization (Millions) 85,163
 Shares Outstanding (Millions) 1,735
 Total Debt (Millions $) 23,974
 Revenue (TTM) (Millions $) 22,303
 Net Income (TTM) (Millions $) 1,503
 Cash Flow (TTM) (Millions $) 5,372
 Capital Exp. (TTM) (Millions $) -1,150
 Dividend TTM ($) 1.04 $
 Dividend Yield TTM (%) 2.16 %
 Employees (TTM) $ 77,000


   



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com